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Proteolytic processing of the nonstructural proteins of the hepatitis C virus (HCV) is mediated by two viral proteinases:
the NS2-3 proteinase cleaving at the NS2/3 junction and the NS3 serine-type proteinase responsible for processing at the
NS3/4A, NS4A/B, NS4B/5A, and NS5A/B sites. Activity of the NS3 proteinase is modulated by NS4A. In the absence of
this cofactor processing at the NS3-dependent sites does not occur or, in the case of the NS5A/B junction, is poor but
increased when NS4A is present. Although recent studies demonstrated that proteinase activation requires direct interaction
between NS3 and NS4A, the mechanism by which NS4A exerts the activation function is not known. To further analyze the
conditions of proteinase activation and to characterize the NS3 sequences important for complex formation and activation
we used an in vitro assay in which radiolabeled HCV substrates were mixed with NS3 proteinase and synthetic NS4A
peptides. We found that microsomal membranes are not required for proteinase activation. However, they are important
for efficient accessibility of the NS4A/B site but not the other trans-cleavage sites. Studies with NS3 deletion mutants
identified a region between amino acids 15 and 22 which is essential for proteinase activation. Results obtained with several
mutations introduced into this sequence show that a weak overall association between NS3 and NS4A is sufficient for
proteinase activation and suggest that a beta-sheet at the NS3 amino terminus plays an important role. Although not
essential for proteinase activation the amino terminal 14 NS3 residues were found to have an auxilliary function probably
by stabilizing the NS3/4A interaction. Finally, we could demonstrate intracellular, peptide-mediated modulation of proteinase
activity providing the basis for the development of a novel therapeutic concept. q 1996 Academic Press, Inc.
INTRODUCTION NS5A, and NS5B is mediated by two virally encoded
enzymes: The NS2-3 proteinase, a zinc-dependent metal-
Hepatitis C virus (HCV) causes the vast majority of loproteinase cleaving between NS2 and NS3 (Grakoui et
transfusion-associated cases of hepatitis and accounts al., 1993a; Hijikata et al., 1993a; Hirowatari et al., 1993),
for a significant proportion of community-acquired hepa- and a serine-type proteinase located in the amino termi-
titis cases worldwide (for a review see Cuthbert, 1994). nal 180 amino acids of NS3 which is essential for cleav-
Most, if not all, infections become chronic and in about ing at all the other sites (Bartenschlager et al., 1993;
50% of cases result in chronic active hepatitis which Eckart et al., 1993; Grakoui et al., 1993b; Hijikata et al.,
may lead after several years to the development of liver 1993a; Manabe et al., 1994; Tomei et al., 1993). Pro-
cirrhosis or hepatocellular carcinoma (for reviews see cessing between NS3 and NS4A is mediated by an intra-
Cuthbert, 1994; McDonnell and Lucey, 1995). molecular reaction, whereas cleavage at the other sites
The genomic RNA of HCV contains a single long open can be mediated in trans (Tomei et al., 1993; Bar-
reading frame encoding a polyprotein of about 3010 tenschlager et al., 1994; Lin et al., 1994b). Although enzy-
amino acids (reviewed by Matsuura and Miyamura, matically active on its own, NS4A, a 54 amino acids long
1993). Numerous studies have shown that this polypro- hydrophobic peptide is essential as a proteinase cofactor
tein is cleaved co- and posttranslationally into mature (Bartenschlager et al., 1994; Failla et al., 1994; Lin et al.,
viral proteins. Processing of the structural proteins lo- 1994b). While cleavage at the NS3/4A, NS4A/B, and
cated in the amino terminal quarter of the polyprotein is NS4B/5A junctions is absolutely dependent on NS4A,
mediated by host cell signalases cleaving in the lumen processing between NS5A and NS5B can be mediated
of the endoplasmic reticulum and generating the putative by NS3 alone but at least for some HCV isolates is greatly
nucleocapsid protein (core) and the envelope glycopro- increased by the NS4A cofactor. Several studies have
teins E1 and E2 (Hijikata et al., 1991; Santolini et al., demonstrated formation of a stable NS3/4A complex
1994; Lin et al., 1994a; Mizushima et al., 1994). Maturation (Bartenschlager et al., 1995a; Failla et al., 1995; Lin et al.,
of the nonstructural proteins NS2, NS3, NS4A, NS4B, 1995a; Tanji et al., 1995). Mutational ablation of complex
formation also impairs cleavage at the NS4A-dependent
sites, suggesting that proteinase activation is achieved1 To whom correspondence and reprint requests should be ad-
via direct NS3/4A interaction. NS4A can exert its activa-dressed. Fax: 0049-6131-395604. E-mail: bartnsch@mzdmza.zdv.
uni-mainz.de. tion function in cis (when expressed as an NS3-4A poly-
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protein) or in trans (when expressed as part of the sub- Plasmid constructions
strate or as a separate molecule). Deletion studies have
The basic vector pTM1-2 and constructs pTM1712-shown that the central NS4A domain is essential for pro-
3011, pTM1007-1711, pTM1659-1711, pTM1027-1238,teinase activation and were extended by several muta-
pTM1034-1238, pTM1041-1238, and pTM1049-1238 havetion analyses identifying within this domain residues par-
been described recently (Bartenschlager et al., 1995a;ticularly important for the activation function (Bar-
Fig. 1).tenschlager et al., 1995a; Lin et al., 1995a; Tanji et al.,
Standard recombinant DNA techniques were used for1995; Shimizu et al., 1996). With respect to the NS3 pro-
construction of all plasmids (Sambrook et al., 1989). Plas-tein recent reports have shown that sequences at the
mids pTM1007-1657 and pTM1007-1657/3A were ob-tainedamino terminus are involved in complex formation and
by insertion of SalI–SpeI fragments from pATA1007–1658proteinase activation function but left open a more de-
or pATA1007–1658/SA, respectively (Bartenschlager ettailed characterization of the residues required (Bar-
al., 1994), into the SalI/SpeI-digested pTM1007–3011 (Bar-tenschlager et al., 1994; Failla et al., 1995; Satoh et al.,
tenschlager et al., 1995a). pTM1659–1972 was constructed1995).
by inserting the HCV fragment obtained by PCR via theUsing an in vitro system essentially as described by
introduced NcoI and SpeI restriction sites into pTM1-2.Lin and coworkers (1995a), which is based on the mixing
Plasmid pTM2337–2516 was obtained in the analogousof in vitro-translated radiolabeled HCV-substrates, in
way using oligonucleotides complementary to sequencesvitro-translated proteinase, and NS4A-specific synthetic
within NS5A or NS5B. To construct plasmid pTM1712–peptides, we studied the mechanism and conditions of
2419/P1F carrying a phenylalanine substitution at the P1proteinase activation and performed a detailed analysis
position of the 4B/5A site a PstI–EcoRI fragment isolatedof the NS3 sequences involved in activation by the NS4A
from pATA4B-5A/P1-C r F (Bartenschlager et al., 1995b)cofactor.
was inserted into pTM1712–2419. Site-directed mutagene-
sis was done by PCR methodology according to the proto-
MATERIALS AND METHODS col of Stappert et al. (1992). In brief, for one mutagenesis
a phosphorylated oligonucleotide introducing the desiredCells and viruses
substitution and a ‘‘tagged’’ oligonucleotide complementary
Cell monolayers of the BHK-21, human TK0 143 and to the encephalomyocarditis virus sequence (EMCV, Elroy-
HeLa cell lines were grown in Dulbecco’s modified mini- Stein et al., 1989) upstream of the HCV insert were hybrid-
mal essential medium (DMEM) supplemented with 2 mM ized to the denatured DNA. The sequence of the tagged
L-glutamine, nonessential amino acids, 100 U penicillin primer is ACTGATCAAGCAGTATGTACTACGAACGTC-
per milliliter, 100 mg streptomycin per milliliter, and 10% TAGGCCC-CCCGAACCA (EMCV-specific sequence in
fetal calf serum (FCS). The recombinant vaccinia virus bold letters; tag sequence underlined). After treatment with
vTF7-3 expressing the RNA polymerase of bacteriophage T4 DNA polymerase and T4 DNA ligase (Biolabs, Bad
T7 has been described recently (Fuerst et al., 1986). Schwalbach/Taunus, Germany) unincorporated oligonucle-
Stocks of recombinant vaccinia viruses were grown in otides were removed using a spin column (Quiagen, Hilden,
TK0 143 cell monolayers and titers of infectious progeny Germany) according to the instruction of the manufacturer
were determined by plaque assay using the same cell and one-tenth of the eluate was used for a PCR with an
line. Homologous recombination into the vaccinia virus oligonucleotide identical to the tag-sequence and an HCV-
genome was done exactly as described recently (Bar- specific antisense primer. Purified fragments were re-
tenschlager et al., 1994). stricted with NcoI and SfiI and inserted into pTM1027–
1238. All transferred fragments were verified by DNA se-
Peptides and antisera quence analysis.
Peptides were synthesized by the procedure of Fmoc In vitro transcription and translation
chemistry (Atherton et al., 1988). After cleavage from the
resin peptides were purified by preparative reverse Plasmid DNAs purified by CsCl density gradient cen-
trifugation were linearized downstream of the HCV insert.phase high performance liquid chromatography (RP-
HPLC). The homogeneity of the purified peptides as con- In case of the NS4B-5A148 and the NS4B-5A148 /P1F sub-
strates, plasmids pTM1712-3011 and pTM1712-2419/P1Ffirmed by analytical RP-HPLC was greater than 95% and
the molecular weight was determined by ion spray-mass were restricted within NS5A, respectively. After phenol/
chloroform extraction and ethanol precipitation DNAsspectrometry. Peptides were dissolved in water or, in
case of pep4A38 – 54 , in Dimethylsulfoxide (DMSO). Mono- were used for in vitro transcription with T7 RNA polymer-
ase (Promega, Madison, WI) according to the instructionspecific antisera directed against fragments of NS3
(amino acids 1007–1246), NS5A (amino acids 2101– of the manufacturer. Following phenol/chloroform extrac-
tion and ethanol precipitation RNAs were used for in vitro2231) and NS5B (amino acids 2419–2622) as well as
NS4A have been described recently (Bartenschlager et translation with a rabbit reticulocyte lysate (Promega) as
recommended by the manufacturer. For radiolabeling ofal., 1994; 1995a).
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proteins an amino acid mixture lacking methionine and for cell lysis and immunoprecipitation (Bartenschlager et
al., 1995a).supplemented with protein labeling mixture (Translabel;
ICN, Meckenheim, Germany) at a final concentration of
800 mCi/ml was added to the lysate. To produce nonradi- RESULTS
oactive proteinases translations were performed with
Establishment of an in vitro trans-cleavage assay
mixtures containing all amino acids. For some transla-
tions 1 ml of canine pancreatic microsomal membranes To characterize the mechanism of NS3 proteinase acti-
vation in more detail we devised an in vitro trans-cleav-(Boehringer Mannheim, Germany) was added to a 25-ml
in vitro translation reaction. age assay essentially as described recently (Lin et al.,
1995a). A radiolabeled HCV polyprotein fragment span-
ning the NS4B/5A junction (4B-5A148 ; Fig. 1) and a nonra-In vitro processing assay
diolabeled NS3 proteinase were generated by separate
in vitro translation reactions and equal amounts of theAfter 1 hr at 307 reactions were terminated by the
addition of cycloheximide and RNaseA to final concen- respective lysates were mixed as described under Mate-
trations of 300 and 10 mg/ml, respectively, followed by
10 min incubation at room temperature. Equal amounts
of proteinase and substrate containing lysates were
mixed and peptide was added to final concentrations
specified in the figure legends. After 120 min at 307
reactions were stopped by the addition of protein sam-
ple buffer (200 mM Tris – HCl, pH 8.0, 5 mM EDTA, 3.3%
sodium dodecyl sulfate (SDS), 2% 2-mercaptoethanol,
10% sucrose, and 0.1% bromophenol blue) and proteins
contained in the reaction mixtures were analyzed
by Tricine – SDS – polyacrylamide gel electrophoresis
(PAGE) or SDS – 12.5% PAGE and fluorography. To de-
termine the peptide concentrations required for maxi-
mal proteinase activation various amounts of a peptide
(1 – 100 mM) were added into a series of cleavage reac-
tions with the NS4B/5A148 substrate and the reaction
with the highest amount of NS4B was determined after
SDS – PAGE and fluorography.
Trans-processing assay in tissue culture
HeLa cells were infected with virus mixtures (vTF7-3
and one or two HCV-recombinant vaccinia viruses) each
at a multiplicity of infection of 4 for 1 hr. After removal of
the inoculum cells were incubated for 2 hr in DMEM
containing 10% FCS at 377. Cells were washed twice in
FCS-free DMEM followed by the addition of methionine- FIG. 1. HCV genome structure and expressed proteins. (A) A sche-
matic representation of the HCV polyprotein organization with the struc-free medium supplemented with peptide at concentra-
tural proteins encoded in the amino terminal quarter followed by thetions specified in the figure legend and Translabel at 60
nonstructural proteins is shown on top. The 5* and 3* nontranslatedmCi/ml. After 4 hr at 377 cells were lysed in NPB (50 mM
regions are indicated by thin lines. A detailed view of the organization
Tris–HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 1% of the nonstructural proteins NS2-NS5B (2 to 5B) corresponding to
sodium deoxycholate, 0.1% SDS supplemented with 1 amino acid 809 to 3011 of our isolate is drawn below. Cleavage sites
for the NS2-3 proteinase and the NS3 proteinase are indicated bymM phenylmethylsulfonyl fluoride, and 0.001 trypsin in-
arrows (f and m, respectively). Numbers above the arrows refer tohibitor units per milliliter of aprotinin (Sigma, Deisenho-
amino acids at the P1 positions of the scissile bonds. (B) Overview offen, Germany)). HCV-specific proteins were isolated
constructs and expressed proteins used in this study. The designations
by immunoprecipitation as described recently (Bar- of the polypeptides expressed with the individual constructs is given
tenschlager et al., 1995a). on the left side with subscript numbers referring to the first and the
last amino acid of the particular NS protein or, in the case of the
NS5A84-B97 substrate, to the number of carboxy terminal or amino termi-Transient expression with the vaccinia virus-T7 hybrid
nal residues of NS5A or NS5B, respectively. Numbers at the sides of
system and detection of NS3/4A complexes the lines refer to the first and the last amino acids of the expressed
proteins. Foreign amino acids introduced by the cloning procedure are
Expression of HCV proteins and detection of protein- given in single-letter code as well as substituting amino acids indicated
by an ‘‘X’’ at the appropriate position of the corresponding protein.ase complex was done as described recently using NPB
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TABLE 1 the solubility and to allow in vitro radiolabeling of the
peptide with [32P]phosphate, a target sequence for pro-NS4A Peptides Used for in Vitro Proteinase Activation
tein kinase A was added to the carboxy terminus of two
Sequencea Positionb Proteinase activation (mM)c of the peptides (RRXSX, Bartenschlager et al., 1992). Pro-
teinase activation was observed with peptides corre-
VLVGGVLAALAAYCLTTG 4–35 10 sponding to NS4A amino acids 4–35, 18–38, and 17–
SVVIVGRIVLSGKPDRRTSS
34 (Fig. 2A, lanes 3–5, respectively). Both peptides corre-LTTGSVVIVGRIVLSGKPAIIT 18–38 30
sponding to further truncations of the central regionCLTTGSVVIVGRIVLSGK 17–34 30
SVVIVGRIRRTSS 22–29 n.a.d (pep4A18 – 29 and pep4A22 – 29 ) and the peptide correspond-
LTTGSVVIVGRI 18–29 n.a.d ing to the hydrophilic NS4A carboxy terminus (pep4A38 –
IPDREVLYREFDEMEEC 38–54 n.a.d
54 ) failed to activate the proteinase. This latter peptide
could only be dissolved in DMSO, which therefore wasa Peptide amino acid sequence; bold letters indicate foreign amino
present in the cleavage reaction at a final concentrationacid sequences not present in NS4A.
of 1%. Lack of activation function was not due to protein-b Amino acid position within NS4A.
c Peptide concentration required for maximal NS3 activation to cleave ase damage by the solvent because cleavage efficiency
at the NS4B/5A site (see Materials and Methods). of the NS3*-4A proteinase was not affected under such
d n.a., not applicable since no activation found up to concentrations assay conditions (compare lanes 10 and 11). Specificityof 100 mM.
of the cleavage reaction was shown by absence of NS4B
in the reactions in which (i) no NS4A peptide was added
rials and Methods. Synthetic NS4A peptides were added (lane 2), (ii) an enzymatically inactive NS3 proteinase was
and proteinase activation was determined by comparing used (NS3*/3A; lane 9), and (iii) an NS4B-5A148 substrate
the amounts of NS4B produced by cleavage with the was used in which the P1 cysteine residue of the cleav-
parental proteinase with the amounts of NS4B obtained age site was substituted by a phenylalanine rendering
by processing with one of the altered enzymes. Expres- this site resistant to NS3-mediated cleavage (lane 12;
sion levels and stabilities of proteinase RNAs were deter- Bartenschlager et al., 1995b). This latter result also sug-
mined by in vitro translations in the presence of protein gested that processing in the system described here
labeling mixture using the same RNA preparation taken occurred at the same position identified by sequence
to generate the nonradiolabeled enzymes. analysis of NS4B generated by intracellular cleavage at
To identify the NS4A region required for optimal pro- the NS4B/5A site (Grakoui et al., 1993b). Although we
teinase activation in this in vitro system we used a panel cannot rule out the possibility that lack of activation by
pep4A22 – 29 was due to the foreign carboxy terminal se-of different peptides. As specified in Table 1, to increase
FIG. 2. Peptide-mediated proteinase activation in vitro. (A) Lysates containing radiolabeled 4B-5A148 substrate were mixed with equal amounts
of proteinases specified above each lane and NS4A-specific peptides were added where indicated to final concentrations of 10 mM. As controls
mock incubation of substrate (lane 1) and incubation of proteinase and peptide with a substrate bearing a phenylalanine substitution at the P1
position of the scissile bonds were included (4B-5A148 /P1F; lane 12). In the reaction analyzed in lane 11, cleavage was performed with an NS3*-
4A proteinase in the presence of 1% DMSO. Proteins were separated by SDS–12.5% PAGE and detected by fluorography. (B) Analysis of the integrity
of the RNAs used for expression of unlabeled proteinase by in vitro translations supplemented with protein labeling mixture. Numbers to the left
in (A) and (B) refer to the position of molecular mass standards (given in kilodaltons); HCV-specific proteins are identified on the right.
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quence, in summary, the results show that the minimal
activation domain as determined in this in vitro assay
maps between amino acid 18–22 at the amino terminus
and 29–34 at the carboxy terminus of the cofactor.
In the experiment shown in Fig. 2 we used 10 mM
peptide as a starting concentration. To determine the
optimal concentration for each peptide more precisely
and to analyze whether the shorter peptides could at
least partially activate the proteinase when used at
higher concentrations each peptide was titrated in this
assay. As summarized in Table 1 the lowest concentra-
tion was required in the case of the longest peptide
with increasing concentrations being necessary for the
shorter peptides to achieve the same cleavage efficiency
(pep4A18 – 38 and pep4A17 – 34 ). Interestingly, the amounts
of NS4B obtained with the activating peptides were about
the same at the optimal peptide concentrations. No acti-
vation was observed in the case of pep4A18–29, pep4A22–29,
and pep4A38 – 54 even when concentrations up to 100 mM
were used in the trans-cleavage assay. Thus, although
pep4A17 – 34 still could activate the proteinase, amino ter-
minal NS4A sequences clearly increased the activation
function. For this reason in all subsequent experiments
we used pep4A4 – 35 at a final concentration of 10 mM.
Microsomal membranes are not essential for
processing at the NS4B/5A and NS5A/B sites
but are important to render the NS4A/B site
accessible for cleavage
Given that NS4A is a hydrophobic, membrane-associ-
ated protein and that the same probably holds true at
least for some of the other nonstructural proteins (Hiji-
kata et al., 1993b; Selby et al., 1993; Tanji et al., 1995),
we analyzed a possible influence of microsomal mem-
branes on proteinase activation and cleavage efficiency
at any of the trans-processing sites. To examine a poten-
tial effect of membranes on the substrate, polyprotein
fragments bearing the NS4A/B, NS4B/5A, or NS5A/B
junctions were generated by in vitro translations in the
absence or presence of canine pancreatic microsomal FIG. 3. Influence of microsomal membranes on proteinase activa-
membranes and used for trans-cleavage reactions under tion. NS4AB (A), NS4B-5A148 (B), or NS5A84-B97 (C) substrates were
translated in the absence or presence of microsomal membranesassay conditions described above. As shown in Fig. 3A
(lanes 1 – 3 and lanes 4 – 6 in each panel, respectively) and incubatedlow cleavage of the NS4A/B substrate was found in the
with proteinase (lanes 2 and 5 in each panel) or with proteinase andabsence of membranes and peptide (lane 2). Pro-
10 mM of pep4A4 – 35 (lanes 3 and 6 in each panel). For further details
cessing efficiency was only moderately increased in the see legend to Fig. 2.
reaction with peptide, suggesting that in the case of the
membrane-free NS4A/B substrate the scissile bond was
only poorly accessible for the proteinase (lane 3). Effi- NS5A/B site in the absence of peptide which was
greatly increased when pep4A4 – 35 was added (Fig. 3C,cient processing, largely independent from peptide was
observed with the NS4A/B translated in the presence of compare lanes 2 and 3; Failla et al., 1994; Bar-
tenschlager et al., 1995a). Processing at this site alsomembranes demonstrating NS3 activation by substrate-
derived NS4A (lane 5, 6). In contrast, in the case of was not affected by microsomal membranes (compare
lane 3 with lane 6).the 4B-5A148 substrate cleavage was independent from
microsomal membranes (Fig. 3B, compare lanes 3 and In the experiment described so far we characterized
the effect of membranes on the cleavability of the various6). In agreement with results from cell culture experi-
ments a low but significant cleavage was found at the trans-processing sites. To analyze whether membranes
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tenschlager et al., 1994; Failla et al., 1995; Satoh et al.,
1995). To analyze whether the same could be found in
this in vitro trans-cleavage system three amino terminal
truncations were tested in parallel with the parental
NS31 – 211 and an enzymatically inactive proteinase
(NS31 – 211 /3A). To simplify all subsequent cloning steps
these deletions were introduced into a truncated NS3
sufficient for full proteolytic activity (amino acids 1–211;
Bartenschlager et al., 1994). If corrected for different ex-
pression levels of proteinases, no difference with respect
to peptide-activated cleavage at the NS4B/5A site was
found between the parental proteinase or an NS3 lacking
7 or 14 amino terminal residues (Fig. 5A, lane 2, 4, 5).
Removal of 22 amino acids led to an enzyme which no
longer could be activated but still had retained its enzy-
matic activity as determined by 4A-independent pro-
cessing between NS5A and NS5B (data not shown). This
result demonstrates that the 14 amino terminal residues
FIG. 4. Comparison of proteinase activation mediated by pep4A4–35 of NS3 are dispensable for activation and suggests that
or NS4A2–54 generated by in vitro translation. (A) Radiolabeled 4B-5A148
the sequence between residues 15 and 22 plays an im-substrate was incubated with the NS31–211 proteinase (lane 2), protein-
portant role.ase and 10 mM pep4A4–35 (lane 3), or proteinase and peptide preincu-
bated with microsomal membranes (Membr.) for 5 min (lane 4). Protein- Sequence comparison between the NS3 amino termi-
ase activation by NS4A obtained by in vitro translation in the absence nus of our isolate (HCV-G01) and that of several other
or presence of microsomal membranes is shown in lanes 5 and 6, HCV isolates reveals a high conservation (Fig. 6). Within
respectively. (B) Determination of the expression levels obtained with
this region secondary structure prediction and hydropho-the same preparations of proteinase and NS4A RNAs by in vitro transla-
tions. For further details see legend to Fig. 2.
exert a direct effect on the activation function of the co-
factor, NS4A was generated by in vitro translation in the
presence or absence of microsomal membranes and
used to activate NS3 cleavage at the NS4B/5A site. As
shown in Fig. 4A, NS4B was readily detected in the reac-
tion using membrane-free NS4A but the signal was sig-
nificantly lower compared to the reaction with NS4A
translated in the presence of membranes (compare lane
5 with lane 6). However, analysis of the control transla-
tions revealed higher amounts of NS4A translated in the
presence of membranes, suggesting that the observed
increase of processing efficiency at least in part is due to
higher amounts of NS4A in the corresponding cleavage
reaction and not to higher activation function (Fig. 4B,
lanes 2 and 3). Furthermore, cleavage efficiency obtained
with pep4A4 – 35 was not increased by preincubation of
the peptide with membranes (compare lane 3 with lane
4). From these results we conclude that (i) the NS4A-
activation function essentially is independent from mem-
branes, (ii) membranes most likely are important for
proper folding of the NS4A-B substrate to render the
cleavage site accessible to the proteinase, and (iii) mem-
branes are dispensable for processing at the NS4B/5A
and NS5A/B junctions. FIG. 5. Amino terminal NS3 sequences are important for peptide-
mediated proteinase activation. (A) 4B-5A148 substrate was either mock
Mutation analysis of the essential NS3 activation incubated (lane 1) or with lysates containing proteinases specified
above each lane and 10 mM pep4A4–35 . (B) Determination of the integritydomain
of proteinase-specific RNAs and expression levels of the various pro-
As shown by several groups deletions at the amino teinases by in vitro translations performed with a radioactive amino
acid mixture.terminus of NS3 reduce or block activation by NS4A (Bar-
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FIG. 6. The hydrophobicity profile of the amino terminal NS3 region as determined by the algorithm of Kyte and Doolittle (1982) with a window
of 6 amino acids is shown in the top. The sequence having a high probability to form a beta-sheet structure according to the algorithm of Chou
and Fasman (1978) is indicated above. An alignment of the NS3 sequence of our isolate (HCV-G01) with the sequences of HCV-isolates given on
the left is drawn below the hydrophobicity profile. The region essential for proteinase activation is marked by the box. Amino acids selected for
mutation analysis are indicated by arrows pointing to the substituting residues. HCV isolates are described in the following references: HCV-1
(Choo et al., 1991); HCV-H (Inchauspe et al., 1991); HCV-BK (Takamizawa et al., 1991); HCV-J (Kato et al., 1990); HCV-T (Chen et al., 1992).
bicity analyses identified several features which might residue and the reduction of the activation. As exempli-
fied for the exchanges of the serine residue at positionbe important for interaction with NS4A: (i) a potential
beta-sheet structure between residues 5 and 22 and (ii) 20 substitution by valine predicted not to interfere with
a beta-sheet structure had no effect on peptide-mediateda hydrophobicity profile characterized by a sequence of
hydrophilic, hydrophobic, and, again, hydrophilic resi- activation. In contrast, substitutions by proline or glu-
tamic acid severely reduced or completely blocked cleav-dues. To experimentally evaluate the possible impor-
tance of these motifs for proteinase activation a mutation age (lanes 14 and 15). Principally the same was observed
for the other mutations between positions 17 and 22analysis was performed. Focussing primarily on the im-
portant sequence between residues 15 and 22, three since, also in these cases, substitutions by acidic amino
acids or proline reduced cleavage significantly whiledifferent types of substituting residues were selected: (i)
hydrophobic amino acids likely to preserve a beta-sheet substitutions by hydrophobic residues had no or, in the
case of the threonine exchange by phenylalanine at posi-structure (V, F, or I), (ii) proline, known to disturb ordered
protein structure, and (iii) negatively charged amino acids tion 19, a moderate effect. Mutations carboxy terminal
of the essential domain also affected cleavage. Whileless favorable for the formation of a beta-sheet (D or
E). The substitutions were introduced into the NS31 – 211 substitutions by valine at position 24 and 26 were well
tolerated, substitutions by proline and valine at positionproteinase and tested for peptide-mediated cleavage at
the NS4B/5A site as described above. As expected muta- 23 and 25, respectively, significantly reduced cleavage,
suggesting that sequences carboxy terminal of the mini-tions amino terminal to the essential activation domain
did not or only moderately reduce proteinase activation mal domain, as defined by the deletion study, also play
an important role for proteinase activation.(Fig. 7A, lane 4–6). More drastic effects were observed
in the case of mutations within the essential domain So far we only used single amino acid exchanges and
observed a remarkable tolerance of the NS3 proteinasewith a clear parallel between the kind of the substituting
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FIG. 7. Substitutions in the amino terminal NS3 region and their effects on proteinase activation. (A) Radiolabeled 4B-5A148 substrate was incubated
with equal amounts of lysate containing a proteinase specified above each lane and 10 mM of pep4A4–35 . Mock incubation of substrate is shown
in lane 1. (B) Determination of the expression levels of the various proteinases by in vitro translations performed with RNAs from the same
preparation. Description of proteinases given above each lane in A also refers to the corresponding lane directly below in B. For detailed description
of double mutants (DM) or the triple mutant (TM) see Table 2.
for mutations in the amino terminal region involved in interaction with NS4A, strengthening the assumption that
proteinase modulation is achieved via direct interactionpeptide-mediated activation (summarized in Table 2). To
extend this observation two or three residues were sub- with the cofactor (for a summary of all mutants see Table
2). However, in some cases coprecipitation was reducedstituted simultaneously and the mutants were tested with
the same trans-cleavage assay. The inhibitory effect ob- although no effect was found in terms of proteinase acti-
vation (e.g., the isoleucine substitution at position 10; Fig.served for substitutions by proline was additive because
introduction of two proline residues led to enzymes 8, lanes 3 and 4). This discrepancy has to be ascribed
to the fact that for technical reasons, coprecipitation ap-which could no longer be activated (double mutation
(DM) 2 and 3, lanes 23 and 24). In contrast, introduction parently is more sensitive toward substitutions than
NS4A-dependent cleavage at the NS4B/5A site (Bar-of two or even three exchanges by hydrophobic amino
acids tolerated as single substitutions had no significant tenschlager et al., 1995a). In summary, the finding that
even simultaneous mutations at several positions withineffect (DM-1 and triple mutation (TM), lanes 22 and 25,
respectively). the NS3 amino terminus have no effect on activation
and the high tolerance for substitutions described for theProteinase activation most likely is mediated via direct
interaction with NS4A. Therefore we analyzed the effects central NS4A domain (Bartenschlager et al., 1995a; Lin
et al., 1995a; Shimizu et al., 1996) show that a weakof the amino terminal substitutions on complex formation.
Since this property could not be examined in the trans- overall interaction is sufficient for proteinase activation
and suggest the existence of multiple interaction sitescleavage system described so far we used coimmuno-
precipitation of NS3 and NS4A coexpressed in cell cul- between the proteinase and its cofactor. Furthermore, as
deduced from the correlation between the nature of theture with the vaccinia virus T7-system (Fig. 8; Bar-
tenschlager et al., 1995a). The NS4A-construct was substituting residue and the influence on the activation
structural integrity of the NS3 amino terminus probablytransfected together with one of the various NS3 muta-
tions into BHK-21 cells previously infected with a recom- forming a beta-sheet structure is important for NS4A-
mediated activation.binant vaccinia virus directing the expression of the RNA
polymerase from bacteriophage T7 (Fuerst et al., 1986).
After metabolic radiolabeling, NS3 and NS4A were iso- Accessory function of the NS3 sequence amino
lated from the cell lysate by immunoprecipitation under terminal of residue 15
nondenaturing conditions. As controls transfections of
the parental proteinase alone or together with NS4A As described above, the amino terminal 14 residues
of NS3 can be removed without affecting proteinase acti-were performed in parallel (lane 43–46). In all cases
mutations affecting proteinase activation also affected vation. On the other hand, NS3 enzymes lacking the first
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TABLE 2 still cleave at the NS5A/B junction in the absence of
NS4A showing that the exchanges had not destroyedSubstitutions in the Amino Terminal NS3 Region and Their Effects
the basic activities of the enzymes (data not shown). Allon Proteinase Activation and Complex Formation with NS4A
together these results show that the sequence between
Mutation Activationa Coprecipitationb amino acids 15 and 22 is essential for NS4A-mediated
activation and that residues amino terminal of this region
wildtype // /
have an auxiliary function most likely by stabilizing the8 Q r V // /
NS3/4A complex.10 T r I // {
10 T r P // {
17 I r V // / Peptide mediated proteinase activation in cell culture
17 I r P / {
Besides directly blocking the proteolytic activity of18 I r F // /
18 I r D / { NS3, inhibition of the NS3/4A interaction may be a further
19 T r F / { attractive target for antiviral therapy. For example syn-
19 T r E / 0 thetic NS4A peptides interacting with NS3 but unable to
20 S r V // /
activate the enzyme would be expected to interfere with20 S r P { 0
polyprotein maturation. As a first step to address this20 S r E 0 n.a.3
22 T r I // / possibility we used pep4A4 – 35 as a model compound to
22 T r P / 0 analyze whether the proteinase could be modulated by
23 G r P { 0 a synthetic peptide intracellularly. Stable recombinant
24 R r V // /
vaccinia viruses were used to express an NS4B-5B sub-25 D r V { 0
strate and the NS31 – 211 proteinase in HeLa cells and26 R r V // /
18 I r F/22 T r I (DM-1) // / various concentrations of pep4A4 – 35 were added directly
17 I r P/20 S r P (DM-2) 0 0 into the medium as described under Materials and Meth-
20 S r P/22 T r P (DM-3) 0 0 ods. Peptide-mediated activation was determined by the
18 I r F/20 S r V/22 T r I (TM) / {
amount of NS5A produced during the 4-hr labeling pe-
riod. As control a coexpression of substrate with thea pep4A4–35 mediated activation (Fig. 7). Mean values from three inde-
pendent experiments. //, amount of NS4B comparable to the amount proteinase and NS4A2 – 54 was included. As shown in Fig.
obtained with the unaltered proteinase; /, 50% reduction of NS4B; 10 (middle panel), low but significant amounts of NS5A{, 50% reduction; 0, no NS4B detectable. were found in cells incubated with 50 mM peptide (laneb Interaction between NS31–211 and NS4A2–54 (Fig. 8). /, comparable 3). Proteinase activation was more efficient when higherto wild type; {, 50% reduction; 0, no coprecipitation.
concentrations of peptide were added but slightly re-c n.a., not applicable since proteinase could not be detected by immu-
noprecipitation. duced the overall expression most likely due to cellular
toxicity (lanes 1 and 2). Although efficiency of proteinase
activation was much lower compared to the in vitro sys-
7 or 14 amino acids form successively less stable com- tem or to activation by coexpressed NS4A2 – 54 (probably
plexes with NS4A (Bartenschlager et al., 1995a; Failla due to poor uptake or low stability of the peptide) this
et al., 1995). Assuming that this region would have an result demonstrates that the NS3 proteinase can be mod-
accessory function by stabilizing the complex we ex- ulated by a synthetic peptide also intracellularly.
pected that substitutions which only have a moderate
effect on proteinase activation would be deleterious if DISCUSSION
introduced into an NS3 lacking amino terminal se-
quences. To experimentally test this assumption we se- In this report a cell-free trans-processing assay system
essentially as described by Lin and coworkers (1995a)lected two single substitutions with a moderate effect on
proteinase activation (19 T r E and 22 T r P) and a was used to study conditions required for proteinase
activation and to characterize NS3 sequences involvedsubstitution without effect (20 S r V). The corresponding
exchanges were introduced into NS38 – 211 and NS315 – 211 in activation by the NS4A cofactor.
In agreement with recent reports we found that the cen-and compared with the parental NS31 – 211 substitutions.
If corrected for the amounts of proteinase translated from tral NS4A region is sufficient to activate the proteinase
(Bartenschlager et al., 1995a; Lin et al., 1995a; Tanji etthe individual RNAs, no effect was found for the valine
substitution at position 20 (Fig. 9A, lanes 8–10). In the al., 1995; Shimizu et al., 1996). However, since a lower
concentration of the aminoterminally extended peptidecase of the glutamic acid substitution at position 19, re-
moval of 7 or 14 amino terminal residues reduced or (pep4A4–35 ) was required for NS3 activation sequences at
the amino terminus of NS4A obviously improve the activa-blocked cleavage, respectively (lanes 5–7). The most
pronounced effect was found for the proline substitution tion function, most likely by stabilizing the NS3/4A interac-
tion (Bartenschlager et al., 1995a; Lin et al., 1995a).at position 22. In this case removal of the first 7 amino
acids was sufficient to block peptide-mediated activation As described by us and two other groups, sequences
at the extreme amino terminus of NS3 are not essential(lane 12). It should be noted that all proteinases could
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FIG. 8. Substitutions in the amino terminal NS3 region and their effects on complex formation with NS4A. BHK-21 cells infected with the
recombinant vaccinia virus vTF7-3 were transfected with pTM1659-1711 (NS4A2 – 54 ) and one of the various proteinase constructs. As control
transfections with the parental proteinase construct alone or together with the NS4A plasmid were performed in parallel (lanes 43 – 46). HCV-
specific proteins were isolated from the cell lysate by immunoprecipitation under nondenaturing conditions and separated by Tricine – SDS –
11% PAGE. Note that the proteinase 20S r E could not be detected by this procedure and therefore is not included in the figure. For a
summary of the results see Table 2.
for proteinase activation but important for stabilization of action with the cofactor (Bartenschlager et al., 1995a;
Failla et al., 1995; Satoh et al., 1995). However, it shouldthe complex (Bartenschlager et al., 1995a; Failla et al.,
1995; Satoh et al., 1995). As also shown now for this in be noted that under certain experimental conditions a
proteinase lacking 28 amino terminal residues still canvitro system, the first 14 residues can be removed without
significantly affecting cleavage at the NS4B/5A site, be activated to cleave at the NS4B/5A site in trans (al-
though the level of activation is very low), suggesting thatwhereas removal of a further 9 amino acids leads to an
NS3 which no longer can be activated. This result identi- some minor interactions between NS3 and NS4A outside
the regions described here is possible or an alternativefies the region between residues 15 and 22 as essential
for activation and suggests that sequences amino termi- activation mechanism exists (Failla et al., 1995).
The nature of the interaction between NS3 and NS4Anal to it have an auxiliary function. This conclusion is
further supported by the observation that substitutions is less clear. As deduced from secondary structure pre-
dictions both the NS3 amino terminus (residues 5–22;within the essential region are deleterious when amino
terminal sequences are missing but are tolerated or re- Fig. 6) and the central NS4A region have a high probabil-
ity for the formation of a beta-sheet. At least for NS3 thisduce proteinase activation moderately when introduced
into an NS3 with an authentic amino terminus. Further- prediction is supported by our mutation analysis showing
that substituting residues likely to preserve this structuremore, removal of amino terminal NS3 sequences impairs
coprecipitation with NS4A, suggesting that the auxiliary are well tolerated, whereas amino acids disturbing or
interfering with a beta-sheet structure are less favorablefunction of this region is mediated by stabilizing the inter-
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principally is sufficient, and attachment of NS3 to ER
membranes. Given that the carboxy terminal NS3 domain
encodes an RNA helicase (Kim et al., 1995), membrane
attachment of NS3 (via NS4A) would primarily be im-
portant for the formation of a membrane-associated repli-
case complex. Possibly in this case requirements for
complex formation are different.
Besides direct inhibition of proteinase activity,
blocking NS3/4A interaction may be a novel concept for
the development of an antiviral therapy. Using an activat-
ing NS4A-peptide as a model compound we could show
that proteinase activity can be modulated intracellularly.
Thus, engineered NS4A-peptides or synthetic com-
pounds dominantly inhibiting the activation function of
authentic NS4A (Shimizu et al., 1996) in principle should
be usable as therapeutics. However, it should be kept
in mind that processing between NS3 and NS4A—prob-
ably the first polyprotein cleavage event mediated by
NS3—is a rapid intramolecular reaction and most likely
is preceeded by a rapid (cotranslational) interaction be-
FIG. 9. Effect of amino terminal NS3 deletions on activation of protein- tween NS3 and NS4A (Tomei et al., 1993; Bartenschlager
ases carrying amino acid substitutions in the essential activation do- et al., 1994; Lin et al., 1994a). Given this rapid and efficient
main. (A) 4B-5A148 substrate was incubated with lysates containing interaction, inhibition of complex formation may be diffi-proteinases specified above each lane in the presence of 10 mM
pep4A4–35 . Proteins were analyzed by SDS–12.5% PAGE as described
in the legend to Fig. 2. (B) Determination of expression levels of protein-
ases obtained with the same preparations of RNAs by in vitro transla-
tions. Description of proteinases given above each lane in A also refers
to the corresponding lane directly below in B.
(proline or acidic amino acids, respectively). This struc-
ture probably can allow formation of multiple interactions
between these two proteins within a relatively short se-
quence of only about 20 amino acids, thereby explaining
the high tolerance of both NS3 and NS4A for substitu-
tions within the activation domains (Bartenschlager et
al., 1995a; Lin et al., 1995a; Shimizu et al., 1996).
How NS4A exerts the activation function is not known.
One possibility is that upon binding of NS4A conforma-
tional changes within NS3 take place making the struc-
ture more ideal for substrate binding and/or catalysis.
However, besides modulation of proteinase structure, the
hydrophobic NS4A is also required for localization of NS3
to membranes of the endoplasmic reticulum (Hijikata et
al., 1993b; Tanji et al., 1995). In this way NS4A would
increase the local concentration of proteinase in close FIG. 10. Intracellular pep4A4–35-mediated proteinase activation. HeLa
proximity to the membrane-associated polyprotein sub- cells were infected either with the recombinant vaccinia virus vTF7-3
alone (lane 9) or together with recombinant vaccinia viruses directingstrate (Selby et al., 1993) and by concentrating NS3 in
the expression of the NS4B-5B substrate, the NS31–211 proteinasesuch a compartment sequester it from rapid degradation
(Prot.), or NS4A2–54 as indicated above the upper panel. Proteins wereby cellular enzymes (Tanji et al., 1995). However, as
radiolabeled metabolically for 4 h in the presence of various concentra-
shown in this study and two other reports (Lin and Rice, tions of pep4A4–35 as given above the lanes and HCV-specific proteins
1995b; Shimizu et al., 1996), microsomal membranes are were isolated by immunoprecipitation from the cell lysate using anti-
sera monospecific for NS5B (upper panel), NS5A (middle panel), ornot essential for NS4A to exert the activation function,
NS3 (lower panel). Identification of HCV-proteins is given on the left ofstrongly suggesting that membrane attachment of NS3
each panel. Since immunoprecipitations were performed under nonde-and protection from rapid degradation are not the main
naturing conditions the appearance of NS4B-5A and NS5B in the immu-
mechanisms of proteinase activation. Rather, interaction noprecipitations with anti-NS5B and anti-NS5A, respectively, is due to
between NS3 and NS4A appears to have a dual role: protein–protein interactions not disrupted under these conditions (up-
per and middle panel, respectively).activation of NS3, for which a rather weak interaction
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are required for proteolytic processing of hepatitis C virus nonstruc-cult to achieve. Further studies will be required to see
tural proteins. J. Virol. 68, 3753–3760.whether peptides or small compounds can inhibit the
Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986). EukaryoticNS3/4A interaction under these conditions and thereby transient-expression system based on recombinant vaccinia virus
block maturation of the HCV nonstructural proteins within that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad.
the infected cell. Sci. USA 83, 8122–8126.
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